Research compound · lyophilised

BPC-157

US$31.00

Incl. VAT, plus shipping

Buy BPC-157 peptide as lyophilised powder in sealed glass vials of 5 mg or 10 mg. BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, a chain of 15 amino acids whose sequence occurs in a protein of human gastric juice. In...
Amount
Volume pricing applied automatically at checkout, mixed compounds count
3+ vials −5% 5+ vials −10% 10+ vials −15%
  • For research use only
  • Lyophilised powder
  • Sealed glass vial
  • Ships from the EU · 1 to 3 working days
  • COA on request for documented batches
Intended use
Laboratory research only. Not for human or veterinary use.
Not a
Medicine, supplement, food or cosmetic
Advice
No dosing or medical advice is provided
Sealed vial
-20 °C for long-term storage, 2 to 8 °C for a few weeks, dry and dark
Reconstituted
Keep at 2 to 8 °C and use within a short period
Solvent
Bacteriostatic water, added slowly along the glass, never shaken
Documented batches
Products marked "COA on file" carry a certificate of analysis
Tests
Identity and purity per batch
Request
Send us the lot number on your vial and we send the report
3 or more vials
5 % off every vial
5 or more vials
10 % off every vial
10 or more vials
15 % off every vial
Mixed orders
Different compounds count together, applied at checkout
Europe
1 to 3 working days, tracked
Dispatch
Same or next working day from our EU warehouse
Packaging
Dry lyophilised powder, plain packaging
Rates
Shown at checkout for your country
Unopened vials
Statutory return period, seal intact
Opened or reconstituted
Cannot be returned for safety reasons
BPC-157 US$31.00 Add

Documented, in stock, shipped from the EU.

1–3 days delivery across Europe

Buy BPC-157 peptide as lyophilised powder in sealed glass vials of 5 mg or 10 mg. BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, a chain of 15 amino acids whose sequence occurs in a protein of human gastric juice. In preclinical work it is a frequently used model peptide for tendon, ligament and gut tissue models.

Buy BPC-157: vial sizes and form

BPC-157 is supplied in two vial sizes. The 5 mg vial suits single experiments, the 10 mg vial is intended for series with several samples. Both contain lyophilised powder under a sealed cap, with the amount and the lot number printed on the label. For research designs that combine BPC-157 with TB-500, the BPC-157 and TB-500 blend contains 10 mg of each compound in one vial. Single vials and the blend side by side are listed under BPC-157 peptides. The powder is stored sealed at -20 °C and reconstituted with bacteriostatic water only when the experiment starts; how much solvent a vial takes is explained in our guide bacteriostatic water per vial.

BPC-157 specifications

CompoundBPC-157, pentadecapeptide
CAS number137525-51-0
Molecular formulaC62H98N16O22
SequenceGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular weightapprox. 1,419 Da
Amount5 mg or 10 mg per vial
FormLyophilised powder, sealed vial
SolventBacteriostatic water

Research areas for BPC-157

BPC-157 goes back to the pharmacology group of the University of Zagreb, which first described the peptide in the early 1990s. Since then it has been studied mainly in animal and cell models. Typical fields are:

  • Tendon, ligament and gut tissue models
  • Angiogenesis and nitric oxide pathway research
  • Peptide stability and analytics (HPLC, mass spectrometry)

These are research fields, not statements about effects in humans. Our guide BPC-157: structure, research and status summarises the published studies, the open questions and the regulatory status.

BPC-157 research status: preclinical, not approved

Almost everything published on BPC-157 comes from cell cultures and animal models, mostly rats. Controlled clinical trials with published results do not exist, and no authority has approved the peptide as a medicine: not the EMA, not the FDA, which in 2023 placed it in its category of bulk substances with safety concerns for compounding. BPC-157 is therefore a compound for preclinical research.

Limits of the BPC-157 data

The research base is narrower than the number of papers suggests. A large share of the studies comes from one working group in Zagreb, independent replication is limited, and animal findings cannot be transferred to humans. Study designs, models and endpoints vary widely, which makes results hard to compare. Anyone planning experiments should read the primary literature with these limits in mind.

BPC-157 and WADA: prohibited under S0

Since 2022 the World Anti-Doping Agency names BPC-157 explicitly in class S0 (non-approved substances) of its Prohibited List. It is banned in and out of competition for every athlete subject to the World Anti-Doping Code.

Legal classification of BPC-157 in the EU

BPC-157 is not a controlled narcotic at EU level, but it has no marketing authorisation either. Whether a product counts as a medicinal product is decided by the national medicines authorities, coordinated by the European Medicines Agency (EMA). We sell BPC-157 as a research chemical for laboratory use only. Check the rules in the country where your laboratory is based before you order.

Questions about BPC-157

Is BPC-157 legal to buy for research in Germany?

As of October 2026, BPC-157 is not listed in the German Narcotics Act (BtMG, annexes I to III) or in the New Psychoactive Substances Act (NpSG), and it has no marketing authorisation as a medicine in the EU. It is sold as a research chemical for laboratory use. If the competent authority classifies a parcel as a medicine, the import ban of section 73(1) of the German Medicines Act applies. The regulatory status is summarised in our guide BPC-157: structure, research and status, linked above.

What is the difference between BPC-157 and the BPC-157 and TB-500 blend?

The single vial contains only BPC-157. The blend contains 10 mg BPC-157 and 10 mg TB-500 in one vial and is intended for research designs that work with both peptides.

Which vial size should a laboratory choose?

Choose the amount you will use within a short period after reconstitution. Several small vials keep more of the compound as stable powder than one large vial that is opened early.

Can I order BPC-157 to any EU country?

Yes. We ship BPC-157 for laboratory research from our warehouse in the Netherlands to all EU member states, usually within 1 to 3 working days, tracked and in neutral packaging. Payment is by bank transfer; the checkout shows the methods currently available. Import rules are national, so check yours first.

Read more about BPC-157

How BPC-157 compares with TB-500 is explained in BPC-157 vs TB-500. To work out concentrations after reconstitution, use the peptide calculator. Single vials and blends are listed under BPC-157 peptides.

For laboratory research use only. Not for human or veterinary use, not a medicine, not a food or cosmetic.

Documented, not assumed

Every vial, documented.

How the compounds are tested, how to get the report, and how to handle the vial.

Laboratory analysis
Per batch
Identity
Mass spectrometry
Purity
HPLC
Appearance
White lyophilised powder
Report
On request, by lot number

Questions about this product

The label states the amount of compound per vial in milligrams as filled. Purity for documented batches is reported in the certificate of analysis.
Bacteriostatic water for almost every compound in our range. It is available in 10 mL vials in the lab supplies category.
Much shorter than the powder. Keep it refrigerated at 2 to 8 °C and plan your research so that solutions are used within a short period.
Across Europe from our EU warehouse, delivery in 1 to 3 working days. Rates for your country are shown at checkout.
Unopened vials with intact seal can be returned within the statutory period. Opened or reconstituted products cannot be taken back.